UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 12 | Issue 10 | October 2025

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 12 Issue 2
February-2025
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2502413


Registration ID:
555512

Page Number

e127-e135

Share This Article


Jetir RMS

Title

IN-SILICO APPROACH FOR POTENTIAL DRUG TARGET IN HUMAN MUTANT COMPLEX WITH NADPH AND AG-881 INHIBITOR

Abstract

Abstract: Computational methods are being used in drug discovery as a result of the growing need for efficient therapeutic interventions. This work focuses on using an in-silico method to find possible drug targets and examine how they interact with an AG-881 (Vorasidenib) inhibitor and NADPH in a human mutant complex. We evaluated the effectiveness of tovorafenib and curcumin as possible therapeutic agents using molecular docking, structural validation, and toxicity prediction. CB-Dock was used for molecular docking in order to assess binding affinities and interactions. The root-mean-square deviation (RMSD) for structural stability analysis was computed using PyMOL. To ascertain the safety profiles of the chosen compounds, toxicity evaluations were carried out using ProTox toxicity identification. Our results imply that Curcumin and Tovorafenib both show encouraging binding affinities and structural stability within the target stability analysis. Toxicity assessments were performed using ProTox to determine the safety profiles of the selected compounds. Our findings suggest that both Tovorafenib and Curcumin exhibit promising binding affinities and structural stability within the target complex, with Curcumin showing a favorable toxicity profile. This study highlights the potential of computational drug discovery in identifying novel therapeutic candidates, contributing to the advancement of precision medicine.

Key Words

Keywords: Molecular docking; binding affinity; Tovorafenib; pharmacophore modelling; structural Analysis; AG-881 inhibitor

Cite This Article

"IN-SILICO APPROACH FOR POTENTIAL DRUG TARGET IN HUMAN MUTANT COMPLEX WITH NADPH AND AG-881 INHIBITOR", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.12, Issue 2, page no.e127-e135, February-2025, Available :http://www.jetir.org/papers/JETIR2502413.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"IN-SILICO APPROACH FOR POTENTIAL DRUG TARGET IN HUMAN MUTANT COMPLEX WITH NADPH AND AG-881 INHIBITOR", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.12, Issue 2, page no. ppe127-e135, February-2025, Available at : http://www.jetir.org/papers/JETIR2502413.pdf

Publication Details

Published Paper ID: JETIR2502413
Registration ID: 555512
Published In: Volume 12 | Issue 2 | Year February-2025
DOI (Digital Object Identifier): http://doi.one/10.1729/Journal.43646
Page No: e127-e135
Country: GREATER NOIDA, Uttar Pradesh, India .
Area: Biological Science
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000194

Print This Page

Current Call For Paper

Jetir RMS